Skip to main content

Table 3 Multivariate analysis of disease-free and overall patient survivals with hepatocellular carcinoma

From: Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma

Variable

Disease-free survival

Overall survival

 

Hazard Ratio

95% C.I.

P value

Hazard Ratio

95% C.I.

P value

Portal invasion (0-4)

2.59

1.27-5.28

0.009

2.74

1.31-5.73

0.007

AFP

2.49

1.09-5.72

0.031

2.03

0.84-4.91

0.114

(≤ 10 ng/mL: > 10 ng/mL)

      

Tumor size

0.58

0.14-2.35

0.445

0.87

0.21-3.56

0.845

(≤ 5 cm: > 5 cm)

      

Intrahepatic metastasis

1.25

0.60-2.60

0.550

1.53

0.66-3.53

0.319

(absent: present)

      

Miran criteria

0.31

0.76-1.27

0.105

0.28

0.07-1.19

0.085

(in: out)

      

tumor FGF19

2.34

1.04-5.26

0.040

3.61

1.56-8.36

0.003

(high: low)

      
  1. AFP alpha-fetoprotein, C.I. confidence interval